Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
US5541166A · kind A · utility
20Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1992 |
| Grant date | Jul 30, 1996 |
| Priority date | — |
| Expiry date | Mar 16, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/715
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of anti-metastatic and/or anti-inflammatory treatment of an animal or human patient comprises administration to the patient of an effective amount of at least one sulphated polysaccharide which blocks or inhibits endoglycosidase, particularly heparanase, activity. Suitable sulphated polysaccharides include heparin and modified heparin, fucoidan, pentosan sulphate, dextran sulphate and carrageenan lambda.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.